Cellebrite
CLBT
209 hedge funds and large institutions have $2.33B invested in Cellebrite in 2025 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 82 increasing their positions, 62 reducing their positions, and 21 closing their positions.
67% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 21
32% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 62
6% more funds holding
Funds holding: 197 → 209 (+12)
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
0.13% less ownership
Funds ownership: 54.08% → 53.95% (-0.13%)
3% less capital invested
Capital invested by funds: $2.4B → $2.33B (-$71.7M)
40% less call options, than puts
Call options by funds: $7.55M | Put options by funds: $12.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$59M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$40.9M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$25.8M |
| 4 |
PP
Pertento Partners
London,
United Kingdom
|
+$23.5M |
| 5 |
VC
Voss Capital
Houston,
Texas
|
+$22.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AE
Axon Enterprise
Scottsdale,
Arizona
|
-$39M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$27.5M |
| 3 |
Handelsbanken Fonder
Stockholm,
Sweden
|
-$25M |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$20.3M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$18.1M |
CLBT Hedge Fund Activity: Q4 2025 in Review
209 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in Cellebrite (CLBT) for Q4 2025, worth a combined $2.33B — down 3% from $2.4B a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new CLBT positions and 21 closed out — a net gain of 14 holders — while 82 added to existing stakes and 62 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $59M. The largest seller was Axon Enterprise, cutting an estimated $39M.
- 209 institutional investors held Cellebrite (CLBT) as of Q4 2025, up from 197 in Q3 2025.
- Funds reported $2.33B of Cellebrite stock for Q4 2025, down 3% quarter-over-quarter.
- 35 funds opened new Cellebrite positions in Q4 2025 and 21 closed out, a net change of +14 holders.
- The largest Cellebrite buyer in Q4 2025 was Fidelity Investments, an estimated $59M added.
- The largest Cellebrite seller in Q4 2025 was Axon Enterprise, an estimated $39M sold.
Based on aggregated 13F filings for Q4 2025.